
|

| |
Track the *RXPAI Index |
 |
|
 | Pain Management Stocks (*RXPAI) |
| |
Pain Management Ideas |
|
|
|
Pain Management Performance |
|
|
|
Pain Management Community |
|
| |
|
Index Description: These medical firms have significant exposure to the growing field of pain management
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.6%
+4.5%
+97.0%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.6%
-0.2%
+77.3%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$548.9M
14.4
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ACRX |
$7.86 |
+0.41 |
+5.5% |
567,386 |
149% |
$277.4M |
- |
246% |
3% |
4 Alerts (0 News) - View
|
|
|
| ACUR |
$2.37 |
+0.01 |
+0.4% |
137,922 |
13% |
$109.4M |
- |
124% |
-47% |
No Alerts/News
|
|
|
| CPIX |
$4.91 |
+0.16 |
+3.4% |
57,369 |
129% |
$88.1M |
- |
22% |
-28% |
No Alerts/News
|
|
|
| DRRX |
$0.85 |
-0.04 |
-4.2% |
105,769 |
12% |
$90.6M |
- |
40% |
-54% |
No Alerts/News
|
|
|
| ENDP |
$33.88 |
-0.40 |
-1.2% |
773,684 |
29% |
$3.8B |
- |
35% |
-12% |
No Alerts/News
|
|
|
| HZNP |
$2.40 |
+0.01 |
+0.4% |
147,217 |
46% |
$148.0M |
- |
22% |
-72% |
No Alerts/News
|
|
|
| OMER |
$5.30 |
+0.22 |
+4.3% |
163,678 |
64% |
$131.6M |
- |
45% |
-61% |
No Alerts/News
|
|
|
| PATH |
$3.17 |
+0.06 |
+1.9% |
93,450 |
61% |
$90.4M |
- |
28% |
-31% |
No Alerts/News
|
|
|
| PCRX |
$29.30 |
-0.43 |
-1.4% |
212,879 |
57% |
$979.8M |
- |
196% |
-5% |
1 Alert (0 News) - View
|
|
|
| PTIE |
$2.82 |
-0.04 |
-1.4% |
162,237 |
28% |
$129.6M |
- |
21% |
-52% |
No Alerts/News
|
|
|
| ZGNX |
$1.53 |
-0.04 |
-2.5% |
164,882 |
26% |
$158.2M |
- |
38% |
-54% |
1 Alert (0 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
NuPathe Announces First Quarter 2013 Financial Results and Operational Highlights PATH
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 14, 07:30AM from (www2.marketwire.com) NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended March 31, 2013, as well as recent operational
Flag
Post a comment
FDA Not Buying Endo Health’s Painkiller Ploy ENDP
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 13, 08:54AM from (ycharts.com) In a sharp rebuff to Endo Health Solutions (ENDP), the FDA has denied a citizen petition that the drugmaker had filed last
Flag
Post a comment
Blue Ridge Capital Starts Endo Health Solutions Position ENDP
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 10, 02:51PM from (www.marketfolly.com) John Griffin's hedge fund firm Blue Ridge Capital filed a 13G with the SEC and just disclosed a 5.98% ownership stake in Endo Health Solutions (ENDP) with 6,635,000 shares.
Flag
Post a comment
Six Hot Stocks to Watch for Friday: Gap, 3D Systems, Pain Therapeutics and More GPS PGNX DDD PTIE SQNM UBNT
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 10, 09:20AM from (247wallst.com) It is Friday, so TGIF. Before you get too deep into your weekend there is still a full trading day and Wall Street has many
Flag
Post a comment
Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Business Update HZNP
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 10, 06:30AM from (www2.marketwire.com) Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for
Flag
Post a comment
Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc. PFE PTIE
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 06:13AM from (globenewswire.com) AUSTIN, Texas, May 10, 2013 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that yesterday it received
Flag
Post a comment
Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results ZGNX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 07:43AM from (globenewswire.com) SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing
Flag
Post a comment
Acura Pharmaceuticals Announces First Quarter 2013 Financial Results ACUR
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 02, 04:10PM from (www2.marketwire.com) Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication
Flag
Post a comment
|
|
|